Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors
Immune-mediated encephalitis as an adverse event due to checkpoint inhibitors is very rare. We describe herein the case of a 38-year-old woman with metastatic triple-negative breast cancer who developed seizures and somnolence twelve days after receiving the first dose of Atezolizumab. Work up ruled...
Saved in:
Main Authors: | Rita Nade (Author), Esther Tannoury (Author), Tamina Rizk (Author), Hady Ghanem (Author) |
---|---|
Format: | Book |
Published: |
University of São Paulo,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review
by: François Zammit, et al.
Published: (2024) -
Cutaneous Adverse Events of Targeted Therapies and Immune-Checkpoint Inhibitors in Patients with Melanoma
by: Rita Pimenta, et al.
Published: (2021) -
Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
by: Zoe Apalla, et al.
Published: (2021) -
Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review
by: Ling Gao, et al.
Published: (2019) -
Gender Differences in the Incidence of Adverse Cardiovascular Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Sheharyar Minhas, MD, et al.
Published: (2020)